Australia markets closed

CanSino Biologics Inc. (CASBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.10000.0000 (0.00%)
At close: 11:28AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.18B
Enterprise value 917.01M
Trailing P/E 10.28
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.47
Price/book (mrq)0.74
Enterprise value/revenue 2.55
Enterprise value/EBITDA -0.49

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-53.33%
S&P500 52-week change 322.38%
52-week high 34.5000
52-week low 31.8600
50-day moving average 32.0949
200-day moving average 32.7694

Share statistics

Avg vol (3-month) 3354
Avg vol (10-day) 3N/A
Shares outstanding 5132.67M
Implied shares outstanding 6561.44M
Float 8162.39M
% held by insiders 126.70%
% held by institutions 115.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 413 July 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-527.50%

Management effectiveness

Return on assets (ttm)-10.36%
Return on equity (ttm)-31.40%

Income statement

Revenue (ttm)357.08M
Revenue per share (ttm)1.45
Quarterly revenue growth (yoy)-44.50%
Gross profit (ttm)N/A
EBITDA -1.48B
Net income avi to common (ttm)-1.48B
Diluted EPS (ttm)-0.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.13B
Total cash per share (mrq)16.72
Total debt (mrq)2.7B
Total debt/equity (mrq)51.06%
Current ratio (mrq)2.02
Book value per share (mrq)21.35

Cash flow statement

Operating cash flow (ttm)-908.23M
Levered free cash flow (ttm)-846.51M